Omnicell price target raised to $45 from $40 at Benchmark

Benchmark raised the firm’s price target on Omnicell (OMCL) to $45 from $40 and keeps a Buy rating on the shares. Omnicell’s Q3 upside and Q4 guidance provide further evidence that the XTExtend and Amplify product offerings launched late last year are gaining increasing traction, the analyst tells investors.